Please login to the form below

Not currently logged in
Email:
Password:

Dsuvia

This page shows the latest Dsuvia news and features for those working in and with pharma, biotech and healthcare.

AcelRX’s potent opioid tablets set to win FDA backing for pain relief

AcelRX’s potent opioid tablets set to win FDA backing for pain relief

Unlike intravenous-based opioids, Dsuvia, which is already approved in the EU, could allow for a more effective and less invasive pain reliever. ... We are pleased with the Advisory Committee’s recommendation to approve Dsuvia as a treatment in

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...